Kawasaki, Japan

Masako Hagihara


Average Co-Inventor Count = 11.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2007-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Masako Hagihara: Innovator in Calcium Channel Antagonists

Introduction

Masako Hagihara is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target N-type calcium channels. With a total of 3 patents to her name, her work has the potential to impact therapeutic approaches for pain management and related diseases.

Latest Patents

Hagihara's latest patents include innovative pyridine and pyrimidine compounds that exhibit selective N-type calcium channel antagonistic activity. These compounds have demonstrated analgesic effects when administered orally, making them valuable as therapeutic agents for various conditions associated with N-type calcium channels. Her research focuses on the development of achiral derivatives that can effectively alleviate pain and improve patient outcomes.

Career Highlights

Masako Hagihara is currently employed at Ajinomoto Co., Ltd., where she continues to advance her research in pharmacology and medicinal chemistry. Her work has garnered attention for its potential applications in treating chronic pain and other related disorders.

Collaborations

Hagihara collaborates with esteemed colleagues, including Seiji Ohno and Seiji Niwa, to further enhance the scope and impact of her research. Their combined expertise contributes to the innovative solutions being developed in the field.

Conclusion

Masako Hagihara's contributions to the field of medicinal chemistry, particularly through her patents on N-type calcium channel antagonists, highlight her role as a leading inventor. Her work not only advances scientific knowledge but also holds promise for improving therapeutic strategies in pain management.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…